...
首页> 外文期刊>Cytokine >Comparison of the levels of the growth factors in umbilical cord serum and human milk and its clinical significance
【24h】

Comparison of the levels of the growth factors in umbilical cord serum and human milk and its clinical significance

机译:脐带血清和人乳中生长因子水平的比较及其临床意义

获取原文
获取原文并翻译 | 示例

摘要

The process of the growth of the fetus begins in the uterus and gets further accelerated following the birth, especially during initial few months. The role of the growth factors in the physiology of the cellular growth is already well established. Vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) seem to be imperative for angiogenesis, cell development and proliferation as well as maintenance of the tissues. The levels of these factors in the maternal serum during pregnancy as well as during postpartum period are insignificant. Consequently, we hypothesized that the fetus receives moderate supply of these growth factors from the placenta during its stay in the uterus. This supply gets further augmented during the postpartum period through the different source, i.e. mother's milk. To study this physiological transition of the source of the growth factors from the placenta to the breast milk, the concentrations of VEGF and HGF in the cord serum of full term neonates and that in the breast milk of the corresponding mothers were analyzed during ELISA. The human milk, especially the colostrum revealed significantly higher levels of VEGF and HGF (1541.759 ± 119.349. pg/ml and 7129.249 ± 273.472. pg/ml) than cord serum (16.632 ± 0.773. pg/ml and 2581.6 ± 108.275. pg/ml) respectively. The multifold higher levels of VEGF observed in colostrum probably correlates with its high neonatal requirement for the maturation of the gastrointestinal epithelium following birth. The higher levels of both the growth factors in the breast milk than those observed in the cord serum probably explain their higher needs by the neonates for immunological protection, protein synthesis and neurocognitive development. The observations of the present study strengthen the policy of the colostrum feeding, which is promoted by organizations like World Health Organization (WHO). This study further documents the fact that the commercial milk formulae cannot replace the human milk.
机译:胎儿的生长过程从子宫开始,并在分娩后进一步加速,特别是在最初的几个月中。生长因子在细胞生长的生理学中的作用已经被充分确立。血管内皮生长因子(VEGF)和肝细胞生长因子(HGF)似乎对于血管生成,细胞发育和增殖以及组织的维持至关重要。在孕期和产后期间,孕妇血清中这些因子的水平微不足道。因此,我们假设胎儿​​在其停留在子宫期间会从胎盘获得适度的这些生长因子供应。在产后期间,通过不同的来源(即母乳)进一步增加了这种供应。为了研究从胎盘到母乳的生长因子来源的这种生理转变,在ELISA中分析了足月新生儿脐带血清和相应母亲的母乳中VEGF和HGF的浓度。与脐带血清(16.632±0.773。pg / ml和2581.6±108.275。pg / ml)。在初乳中观察到的VEGF含量较高的倍数可能与其对新生儿出生后胃肠道上皮成熟的高新生儿需求有关。母乳中两种生长因子的水平都比脐带血清中观察到的水平高,这可能解释了新生儿对免疫保护,蛋白质合成和神经认知发育的更高需求。本研究的观察结果加强了初乳喂养的政策,这是由世界卫生组织(WHO)等组织推动的。这项研究进一步证明了商业牛奶配方不能替代人乳这一事实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号